NDC 51350-012-11 - CURACAINE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51350-012
- Requested NDC
- 51350-012-11
- Package NDCs from labels
- 51350-012-11, 51350-012-51
- Manufacturer
- Transdermal Corp
- Effective date
- 2017-02-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CURACAINE - Transdermal Corp | Transdermal Corp | 2017-02-14 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 51350-012-51 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-55c3-f424-e053-dadaa90a57ce | 415368d8-12de-4688-8cf8-33382fca0dca |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51350-012-11 | CURACAINE | 30 mL in 1 TUBE | CREAM | 30 | 15 | |
| 51350-012-51 | CURACAINE | 1 in 1 BOX | CREAM | 1 | 15 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LIDOCAINE HYDROCHLORIDE | LIDOCAINE HYDROCHLORIDE | Henry Schein, Inc. | 23c8f711-e458-479a-9ab0-dcc851311e24 | 2026-09-10 | Warnings, Adverse reactions | V13007Z41A |
| Burn Cream | BENZALKONIUM CHLORIDE, LIDOCAINE HCI | Trifecta Pharmaceuticals USA LLC | e9a9fc7c-31da-ea3f-e053-2a95a90a0eab | 2026-09-09 | Warnings | V13007Z41A |
| Burn Gel | LIDOCAINE HCI | Trifecta Pharmaceuticals USA LLC | e9d3e9be-1036-fad0-e053-2a95a90a6efe | 2026-09-09 | Warnings | V13007Z41A |
| Leader Eye Drops Redness Relief | GLYCERIN, NAPHAZOLINE HYDROCHLORIDE | Cardinal Health | aee4bbe2-4f11-4c54-be8b-df48b3ba4f3a | 2026-09-09 | Warnings | PDC6A3C0OX |
| Hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | Rite Aid Corporation | 407c78ca-6fee-4ed6-b61b-711ec049c86e | 2026-09-09 | Warnings | PDC6A3C0OX |
| Clear Eyes Nighttime | GLYCERIN | Prestige Brands Holdings, Inc. | af75e2f7-81dd-43e0-a390-b52bbfbebf62 | 2026-09-08 | Warnings | PDC6A3C0OX |
| American Safety First Aid | LIDOCAINE HCL | Orazen Inc | ea2f776b-dfd0-6ce4-e053-2995a90af009 | 2026-09-07 | Warnings | V13007Z41A |
| MEDI-FIRST Topical Analgesic | LIDOCAINE HCI | Ultra Distributors Inc | b6f288f7-9ae3-215e-e053-2a95a90aedf6 | 2026-09-07 | Warnings | V13007Z41A |
| MEDI-FIRST | BENZALKONIUM CHLORIDE, LIDOCAINE | Orazen Inc | f508434f-5948-7134-e053-2a95a90a03d7 | 2026-09-05 | Warnings | V13007Z41A |
| MEDI-FIRST | BENZALKONIUM CHLORIDE, LIDOCAINE | Orazen Inc | f522fb0b-3d86-b228-e053-2a95a90a55e9 | 2026-09-05 | Warnings | V13007Z41A |
| Nerve Guard Nerve Relief | LIDOCAINE HYDROCHLORIDE, MENTHOL,MAGNESIUM CHLORIDE | Micelle Laboratories, Incorporated | 6b78f40f-2a7f-4c49-96af-1a95acbf430f | 2026-09-04 | Warnings | V13007Z41A |
| Hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | CVS Pharmacy | 3167c918-a7d3-46a1-a85b-64f9c22916f2 | 2026-09-04 | Warnings | PDC6A3C0OX |
| Lidocaine Viscous | LIDOCAINE HYDROCHLORIDE | REMEDYREPACK INC. | 6f8d20d2-6a91-4a5b-bfe8-f1baada38442 | 2026-09-03 | Boxed warning, Warnings, Adverse reactions | V13007Z41A |
| Nail Treatment Liquid | GLYCERIN | Shantou Ximonth Biotechnology Co., Ltd. | 5a7cd607-a50e-17d0-e063-6294a90acdb2 | 2026-09-02 | Warnings | 724GKU717M |
| HUSTLE BUTTER NUMBING | LIDOCAINE HCL, BENZALKONIUM CHLORIDE | H.B.D. DIST. INC. | 5b4d0390-dac6-4a71-9fdc-5c31543e7c5a | 2026-09-02 | Warnings | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | PAI Holdings, LLC dba PAI Pharma | 9920daef-b156-4a14-b641-f714191ffb5c | 2026-09-02 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | REMEDYREPACK INC. | f824b48c-7039-4ce1-b3df-b3597aba5beb | 2026-08-28 | Warnings, Adverse reactions | V13007Z41A |
| HUSTLE BUTTER NUMBING | LIDOCAINE HYDROCHLORIDE | H.B.D. D.I.S.T. INC. | d7dfb312-6c80-4a2d-b8b2-d9891cb0b74e | 2026-08-24 | Warnings | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | ad1ef0a8-88db-4648-c098-d009eaeb4e5b | 2026-08-20 | Warnings, Adverse reactions | V13007Z41A |
| Rohto Optic Glow | NAPHAZOLINE HYDROCHLORIDE, POVIDONE, PROPYLENE GLYCOL | The Mentholatum Company | df9c5f7c-96e6-4b2b-b8cb-21a6a3342dff | 2026-08-20 | Warnings | 6DC9Q167V3 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.